Research - Irvine, California, United States
Innovative NeuroTechnologies, Inc. (INT) is a development-stage biotechnology company operating in "virtual mode" that is currently pursuing a pipeline of novel biologically-based and disease-modifying therapeutic solutions to prevent, delay, or mitigate the underlying dementia or cognitive decline associated with a spectrum of neurodegenerative disorders referred to as tauopathies, which includes:• Alzheimer's disease (AD),• Frontotemporal dementia (FTD or Pick's disease),• Chronic traumatic encephalopathy (CTE) or dementia pugilistica,• Progressive supranuclear palsy (PSP), • Corticobasal degeneration (CBD), • Familial form of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), and• Parkinson's disease dementia (PDD).The pathology of these seemingly disparate conditions is similar in that they involve dysregulation of the Tau protein and development of neurofibrillary tangles (NFTs), synaptic dysfunction, and/or neuronal loss, which underlie the observed dementia or cognitive deficits. Unfortunately, there are no effective therapies presently available for this spectrum of disorders, and neurodegenerative tauopathies remain a very significant socioeconomic burden and tremendous unmet medical need worldwide.
Outlook
Cloudflare DNS
Google Font API
Mobile Friendly
CloudFlare Hosting